Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 6:25 pm Purchase | 13G | Verastem Inc. VSTM | ORBIMED ADVISORS LLC | 4,148,862 9.900% | 2,619,747 (+171.32%) | View |
| 2024-11-14 4:38 pm Purchase | 13G | Verastem Inc. VSTM | BIOTECHNOLOGY VALUE FUND L P | 4,279,521 9.990% | 1,662,119 (+63.50%) | View |
| 2024-11-14 4:36 pm Purchase | 13G | Verastem Inc. VSTM | Alyeska Investment Group L.P. | 2,859,954 7.110% | 2,859,954 (New Position) | View |
| 2024-11-14 4:30 pm Sale | 13G | Verastem Inc. VSTM | VIKING GLOBAL INVESTORS LP | 0 0.000% | -2,531,829 (Position Closed) | View |
| 2024-11-14 3:33 pm Purchase | 13G | Verastem Inc. VSTM | Soleus Private Equity Fund III L.P. | 3,994,629 8.700% | 3,994,629 (New Position) | View |
| 2024-11-14 09:02 am Sale | 13G | Verastem Inc. VSTM | Flynn James E | 0 0.000% | -1,538,461 (Position Closed) | View |
| 2024-11-13 5:39 pm Sale | 13G | Verastem Inc. VSTM | Stonepine Capital Management LLC | 2,643,620 6.400% | -23,046 (-0.86%) | View |
| 2024-11-12 09:35 am Unchanged | 13G | Verastem Inc. VSTM | Adage Capital Management L.P. | 0 0.000% | 0 (Unchanged) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | Verastem Inc. VSTM | BlackRock Inc. | 2,234,699 5.600% | 0 (Unchanged) | View |
| 2024-10-24 2:02 pm Purchase | 13G | Verastem Inc. VSTM | BlackRock Inc. | 2,234,699 5.600% | 2,234,699 (New Position) | View |
| 2024-07-29 4:04 pm Purchase | 13G | Verastem Inc. VSTM | Stonepine Capital Management LLC | 2,666,666 6.700% | 2,666,666 (New Position) | View |
| 2024-02-14 7:31 pm Purchase | 13G | Verastem Inc. VSTM | ORBIMED ADVISORS LLC | 1,529,115 6.100% | 1,529,115 (New Position) | View |
| 2024-02-14 10:00 am Purchase | 13G | Verastem Inc. VSTM | VIKING GLOBAL INVESTORS LP | 2,531,829 9.990% | 1,211,173 (+91.71%) | View |
| 2024-02-14 09:20 am Purchase | 13G | Verastem Inc. VSTM | BIOTECHNOLOGY VALUE FUND L P | 2,617,402 9.990% | 2,617,402 (New Position) | View |
| 2024-02-13 5:01 pm Purchase | 13G | Verastem Inc. VSTM | Vivo Opportunity LLC | 1,538,461 6.100% | 1,538,461 (New Position) | View |
| 2024-02-02 09:49 am Purchase | 13G | Verastem Inc. VSTM | Soleus Capital Master Fund L.P. | 1,425,634 6.800% | 128,265 (+9.89%) | View |
| 2023-08-31 5:28 pm Purchase | 13G | Verastem Inc. VSTM | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,300,000 5.150% | 1,300,000 (New Position) | View |
| 2023-08-10 4:39 pm Sale | 13G | Verastem Inc. VSTM | BAKER BROS. ADVISORS LP | 0 0.000% | -1,345,192 (Position Closed) | View |
| 2023-07-27 4:30 pm Purchase | 13G | Verastem Inc. VSTM | Soleus Capital Master Fund L.P. | 1,297,369 5.100% | 1,297,369 (New Position) | View |
| 2023-06-22 5:46 pm Purchase | 13G | Verastem Inc. VSTM | Flynn James E | 1,538,461 6.100% | 1,538,461 (New Position) | View |